| NCT ID | NCT06876168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kirby Mayer |
| Condition | Acute Respiratory Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 32 participants |
| Start Date | 2025-07-02 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 32 participants in total. It began in 2025-07-02 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project is designed to have patients participate in a virtual environment with various tasks such as breathing exercises, games to help the brain, and techniques that promote relaxation while hospitalized in the Intensive Care Unit (ICU). The participation in research will last about 5 days and take about 15 to 45 minutes each day.
Eligibility Criteria
Inclusion Criteria: * Admitted to ICU at University of Kentucky for acute respiratory failure, sepsis or other Exclusion Criteria: * Are less than 18 years of age * Have a pre-existing neurologic disorder * Have a pre-existing emotional or personality disorder * Have a history or active mental health disorder or disease * Experienced an acute neurologic event (e.g., stroke) * Are currently pregnant * Are a prisoner * Receiving hospice care * Have existing open wounds or pressure ulcers on head or neck
Contact & Investigator
Kirby P. Mayer, Ph.D.
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT06876168 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Acute Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06876168 currently recruiting?
Yes, NCT06876168 is actively recruiting participants. Contact the research team at lasu229@uky.edu for enrollment information.
Where is the NCT06876168 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT06876168 clinical trial?
NCT06876168 is sponsored by Kirby Mayer. The principal investigator is Kirby P. Mayer, Ph.D. at University of Kentucky. The trial plans to enroll 32 participants.